Globally, gastric cancer is the fifth most common malignancy and the fourth leading cause of cancer-related death, with China bearing nearly half of these cases. These figures underscore an urgent need for innovative solutions in the field, particularly given the huge disparities in access to diagnostic and treatment resources in remote and underserved areas.
5G-enabled robotic surgery: A new era in gastric cancer treatment
Globally, gastric cancer is the fifth most common malignancy and the fourth leading cause of cancer-related death, with China bearing nearly half of these cases. These figures underscore an urgent need for innovative solutions in the field, particularly given the huge disparities in access to diagnostic and treatment resources in remote and underserved areas.